Featured Research

from universities, journals, and other organizations

Significant rise in older people living, being diagnosed with HIV in UK

Date:
March 13, 2014
Source:
Oxford University Press (OUP)
Summary:
Despite a year-on-year increase in the number of people over the age of 50 being diagnosed with the Human Immunodeficiency Virus (HIV), there is a reluctance of healthcare professionals to offer HIV tests to older people. This results in high rates of “late presentation” and therefore significantly increased mortality.

A new paper published online in the British Geriatrics Society journal Age and Ageing argues that despite a year-on-year increase in the number of people over the age of 50 being diagnosed with the Human Immunodeficiency Virus (HIV), there is a reluctance of healthcare professionals to offer HIV tests to older people. This results in high rates of "late presentation" and therefore significantly increased mortality.

According to the article by Dr Eva Bunting and colleagues, of the Royal Sussex County Hospital, the proportion of older patients in the UK living with HIV has increased significantly. They quote the most recent Public Health England data, which shows that of an estimated 73,660 people living with HIV, in 2002 12% (3,640) were over 50 years old, while in 2011 that figure rose to 22% (16,550). In Brighton, where Professor Martin Fisher is based, this figure is as high as 35%.

There have been dramatic developments in HIV management since the introduction of combination antiretroviral therapy (cART) in 1996, but as the population of older people living with HIV increases, new challenges continue to emerge. It has been suggested that people living with HIV may age quicker than the general population; this has yet to be proven and is the subject of current research (such as the POPPY study in the UK). What is certain, however, is that an increased older population living with HIV means that there needs to be more careful thought put into how to care for these patients, especially in terms of other conditions they may have.

Professor C Rajkumar says, "It is clear that the HIV cohort is aging and that non-HIV physicians -- including elderly care physicians -- will be increasingly involved in the care of these patients. In the UK, the medical care of patients with HIV has historically been largely within either genitourinary medicine or infectious diseases clinics.

"As this relatively new chronic illness develops, HIV physicians could learn from the experience in management of other complex chronic diseases, incorporating an awareness of the need for a more comprehensive approach, taking account of the mental, functional, and social aspects, as well as medical issues. It is increasingly apparent that HIV specialists are less confident and less likely to treat significant co-morbidities such as diabetes and hypertension."

However, when HIV patients are treated by other specialties, it is increasingly recognised that care may be suboptimal. In particular, there are risks associated with patients taking a number of different drugs at the same time, and doctors therefore need to be aware of potential interactions between different medications. This risk can be tempered by discussion and collaboration between HIV physicians and other specialities, as well as pharmacists.

Professor Martin Fisher also warns that the diagnosis of HIV is often missed in older persons, resulting in high rates of "late presentation" (63%) and significantly increased mortality.

He says: "Even when HIV testing is introduced as a routine test, there is a reluctance of healthcare professionals to offer HIV tests to older persons. This is despite a year-on-year increase in the number of older individuals being diagnosed for the first time with HIV. Geriatricians need to enhance their diagnostic consideration of undiagnosed HIV infection and offer HIV testing to persons with clinical indicator diseases, irrespective of age."


Story Source:

The above story is based on materials provided by Oxford University Press (OUP). Note: Materials may be edited for content and length.


Journal Reference:

  1. E. Bunting, C. Rajkumar, M. Fisher. The human immunodeficiency virus and ageing. Age and Ageing, 2014; DOI: 10.1093/ageing/afu016

Cite This Page:

Oxford University Press (OUP). "Significant rise in older people living, being diagnosed with HIV in UK." ScienceDaily. ScienceDaily, 13 March 2014. <www.sciencedaily.com/releases/2014/03/140313092441.htm>.
Oxford University Press (OUP). (2014, March 13). Significant rise in older people living, being diagnosed with HIV in UK. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/03/140313092441.htm
Oxford University Press (OUP). "Significant rise in older people living, being diagnosed with HIV in UK." ScienceDaily. www.sciencedaily.com/releases/2014/03/140313092441.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins